Prostate Cancer and the Mevalonate Pathway

Prostate Cancer and the Mevalonate Pathway

Antineoplastic therapies for prostate cancer (PCa) have traditionally centered around the androgen receptor (AR) pathway, which has demonstrated a significant role in oncogenesis. Nevertheless, it is becoming progressively apparent that therapeutic strategies must diversify their focus due to the em...

Full description

Bibliographic Details
Main Authors: Patricia Guerrero-Ochoa, Sergio Rodríguez-Zapater, Alberto Anel, Luis Mariano Esteban, Alejandro Camón-Fernández, Raquel Espilez-Ortiz, María Jesús Gil-Sanz, Ángel Borque-Fernando
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
prostate cancer
cholesterol
statins
mevalonate pathway
antitumoral
Online Access:https://www.mdpi.com/1422-0067/25/4/2152

Internet

https://www.mdpi.com/1422-0067/25/4/2152

Similar Items